{Reference Type}: Journal Article
{Title}: From Histiocytoid Sweet Syndrome to Myelodysplasia Cutis: History and Perspectives.
{Author}: Vignon-Pennamen MD;Battistella M;
{Journal}: Dermatol Clin
{Volume}: 42
{Issue}: 2
{Year}: 2024 Apr
{Factor}: 3.645
{DOI}: 10.1016/j.det.2023.08.004
{Abstract}: In 2005, a new histologic variant of Sweet syndrome (SS) has been described and termed histiocytoid SS (HSS). Clinically, patients had a typical SS, but on skin biopsy, the infiltrates were composed of immature nonblast myeloid cells. Nearly 50% of patients with HSS have myelodysplastic syndrome (MDS). HSS may be the first manifestation leading to the diagnosis of MDS. In 2015, a new category of myeloid dermatosis has been proposed, called myelodysplasia cutis, describing the specific skin infiltration by myelodysplastic cells in patients with MDS.